Intensity Therapeutics (INTS) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
3 Feb, 2026Opening remarks and agenda
The meeting was called to order at 10:30 A.M. Eastern Time and held virtually to improve stockholder access.
The agenda was made available online, with a Q&A session scheduled at the end.
Board and executive committee updates
Directors present included Dr. Emer Leahy, Dr. Mark Goldberg, Daniel Donovan, and Thomas Dubin.
Daniel Donovan and Thomas Dubin were candidates for re-election.
Joseph Talamo (CFO) and John Wesolowski (Controller) were introduced, along with legal counsel and the Inspector of Election.
Shareholder proposals
Proposals included the election of two directors, approval of the 2024 Employee Stock Purchase Plan, and ratification of EisnerAmper LLP as auditors.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Intensity Therapeutics
- Net loss narrowed to $2.4M in Q1 2026; clinical progress and funding remain critical.INTS
Q1 20267 May 2026 - Shareholders will vote on director elections, equity plan changes, and auditor ratification at the 2026 virtual meeting.INTS
Proxy filing30 Apr 2026 - Virtual meeting to vote on director elections, auditor, and equity plan amendments.INTS
Proxy filing30 Apr 2026 - Promising clinical results and strong 2025 capital raise extend cash runway into Q2 2027.INTS
Q4 202527 Mar 2026 - Shelf registration enables up to $150M in offerings, supporting late-stage oncology trials.INTS
Registration Filing16 Dec 2025 - Registering 394,500 shares for resale; lead cancer drug advancing to Phase 3.INTS
Registration Filing16 Dec 2025 - Shareholders to vote on a reverse stock split and potential adjournment to maintain Nasdaq compliance.INTS
Proxy Filing2 Dec 2025 - Shareholders will vote virtually on director election and auditor ratification, with board approval recommended.INTS
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, ESPP, and auditor, with all proposals board-recommended.INTS
Proxy Filing2 Dec 2025